2012 annual financial data
Rigel Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -4,416.76%.
Operating income was -99,377,000 USD and net income was -98,840,000 USD.
Operating cash flow was -85,192,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,250,000 USD
- Operating income
- -99,377,000 USD
- Net income
- -98,840,000 USD
- Operating cash flow
- -85,192,000 USD